Logo image of IMXI

INTERNATIONAL MONEY EXPRESS (IMXI) Stock Fundamental Analysis

NASDAQ:IMXI - Nasdaq - US46005L1017 - Common Stock - Currency: USD

11.06  -0.01 (-0.09%)

After market: 11.06 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to IMXI. IMXI was compared to 101 industry peers in the Financial Services industry. While IMXI has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on IMXI. With these ratings, IMXI could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year IMXI was profitable.
In the past year IMXI had a positive cash flow from operations.
Each year in the past 5 years IMXI has been profitable.
IMXI had a positive operating cash flow in 4 of the past 5 years.
IMXI Yearly Net Income VS EBIT VS OCF VS FCFIMXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

IMXI's Return On Assets of 11.11% is amongst the best of the industry. IMXI outperforms 93.07% of its industry peers.
The Return On Equity of IMXI (39.13%) is better than 94.06% of its industry peers.
IMXI's Return On Invested Capital of 22.16% is amongst the best of the industry. IMXI outperforms 94.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMXI is significantly above the industry average of 11.69%.
The 3 year average ROIC (20.03%) for IMXI is below the current ROIC(22.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.11%
ROE 39.13%
ROIC 22.16%
ROA(3y)11.41%
ROA(5y)12.2%
ROE(3y)40.58%
ROE(5y)38.06%
ROIC(3y)20.03%
ROIC(5y)20.57%
IMXI Yearly ROA, ROE, ROICIMXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30 40

1.3 Margins

Looking at the Profit Margin, with a value of 8.35%, IMXI is in line with its industry, outperforming 48.51% of the companies in the same industry.
IMXI's Profit Margin has improved in the last couple of years.
IMXI has a Operating Margin (14.69%) which is in line with its industry peers.
IMXI's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.69%
PM (TTM) 8.35%
GM N/A
OM growth 3Y0.47%
OM growth 5Y5.87%
PM growth 3Y-4.31%
PM growth 5Y7.81%
GM growth 3YN/A
GM growth 5YN/A
IMXI Yearly Profit, Operating, Gross MarginsIMXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IMXI is creating value.
The number of shares outstanding for IMXI has been reduced compared to 1 year ago.
Compared to 5 years ago, IMXI has less shares outstanding
The debt/assets ratio for IMXI is higher compared to a year ago.
IMXI Yearly Shares OutstandingIMXI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IMXI Yearly Total Debt VS Total AssetsIMXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

IMXI has an Altman-Z score of 3.65. This indicates that IMXI is financially healthy and has little risk of bankruptcy at the moment.
IMXI has a Altman-Z score of 3.65. This is amongst the best in the industry. IMXI outperforms 88.12% of its industry peers.
IMXI has a debt to FCF ratio of 12.70. This is a negative value and a sign of low solvency as IMXI would need 12.70 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.70, IMXI is in line with its industry, outperforming 50.49% of the companies in the same industry.
A Debt/Equity ratio of 1.06 is on the high side and indicates that IMXI has dependencies on debt financing.
IMXI has a Debt to Equity ratio (1.06) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 12.7
Altman-Z 3.65
ROIC/WACC2.82
WACC7.85%
IMXI Yearly LT Debt VS Equity VS FCFIMXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.75 indicates that IMXI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.75, IMXI is in the better half of the industry, outperforming 71.29% of the companies in the same industry.
A Quick Ratio of 1.75 indicates that IMXI should not have too much problems paying its short term obligations.
The Quick ratio of IMXI (1.75) is better than 73.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.75
IMXI Yearly Current Assets VS Current LiabilitesIMXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 4.00% over the past year.
Measured over the past years, IMXI shows a very strong growth in Earnings Per Share. The EPS has been growing by 26.76% on average per year.
IMXI shows a decrease in Revenue. In the last year, the revenue decreased by -1.69%.
Measured over the past years, IMXI shows a quite strong growth in Revenue. The Revenue has been growing by 15.56% on average per year.
EPS 1Y (TTM)4%
EPS 3Y21.98%
EPS 5Y26.76%
EPS Q2Q%-18.6%
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y12.78%
Revenue growth 5Y15.56%
Sales Q2Q%-4.06%

3.2 Future

IMXI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.74% yearly.
The Revenue is expected to grow by 1.48% on average over the next years.
EPS Next Y-8.8%
EPS Next 2Y2.91%
EPS Next 3Y4.74%
EPS Next 5YN/A
Revenue Next Year-3.03%
Revenue Next 2Y-0.05%
Revenue Next 3Y1.48%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IMXI Yearly Revenue VS EstimatesIMXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
IMXI Yearly EPS VS EstimatesIMXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 5.32, which indicates a rather cheap valuation of IMXI.
Based on the Price/Earnings ratio, IMXI is valued cheaply inside the industry as 90.10% of the companies are valued more expensively.
IMXI is valuated cheaply when we compare the Price/Earnings ratio to 25.91, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 4.83, the valuation of IMXI can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of IMXI indicates a rather cheap valuation: IMXI is cheaper than 88.12% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of IMXI to the average of the S&P500 Index (21.85), we can say IMXI is valued rather cheaply.
Industry RankSector Rank
PE 5.32
Fwd PE 4.83
IMXI Price Earnings VS Forward Price EarningsIMXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

IMXI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IMXI is cheaper than 96.04% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as IMXI.
Industry RankSector Rank
P/FCF 29.22
EV/EBITDA 3.05
IMXI Per share dataIMXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

IMXI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.2
EPS Next 2Y2.91%
EPS Next 3Y4.74%

0

5. Dividend

5.1 Amount

IMXI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTERNATIONAL MONEY EXPRESS

NASDAQ:IMXI (5/22/2025, 8:14:10 PM)

After market: 11.06 0 (0%)

11.06

-0.01 (-0.09%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners88.98%
Inst Owner Change-0.79%
Ins Owners4.48%
Ins Owner Change1.94%
Market Cap338.99M
Analysts72.86
Price Target20.4 (84.45%)
Short Float %4.84%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.81%
Min EPS beat(2)-16.98%
Max EPS beat(2)-6.64%
EPS beat(4)1
Avg EPS beat(4)-6.41%
Min EPS beat(4)-16.98%
Max EPS beat(4)2.89%
EPS beat(8)4
Avg EPS beat(8)-2.49%
EPS beat(12)8
Avg EPS beat(12)0.76%
EPS beat(16)11
Avg EPS beat(16)2.49%
Revenue beat(2)0
Avg Revenue beat(2)-4.22%
Min Revenue beat(2)-4.43%
Max Revenue beat(2)-4.02%
Revenue beat(4)0
Avg Revenue beat(4)-3.73%
Min Revenue beat(4)-4.43%
Max Revenue beat(4)-2.65%
Revenue beat(8)0
Avg Revenue beat(8)-3.23%
Revenue beat(12)0
Avg Revenue beat(12)-2.8%
Revenue beat(16)3
Avg Revenue beat(16)-1.39%
PT rev (1m)-7.41%
PT rev (3m)-22.48%
EPS NQ rev (1m)-9.65%
EPS NQ rev (3m)-18.47%
EPS NY rev (1m)-11%
EPS NY rev (3m)-20.1%
Revenue NQ rev (1m)-4.22%
Revenue NQ rev (3m)-5.75%
Revenue NY rev (1m)-3.26%
Revenue NY rev (3m)-5.69%
Valuation
Industry RankSector Rank
PE 5.32
Fwd PE 4.83
P/S 0.52
P/FCF 29.22
P/OCF 7.35
P/B 2.43
P/tB 5.85
EV/EBITDA 3.05
EPS(TTM)2.08
EY18.81%
EPS(NY)2.29
Fwd EY20.68%
FCF(TTM)0.38
FCFY3.42%
OCF(TTM)1.51
OCFY13.61%
SpS21.29
BVpS4.54
TBVpS1.89
PEG (NY)N/A
PEG (5Y)0.2
Profitability
Industry RankSector Rank
ROA 11.11%
ROE 39.13%
ROCE 31.52%
ROIC 22.16%
ROICexc 44.23%
ROICexgc 94.78%
OM 14.69%
PM (TTM) 8.35%
GM N/A
FCFM 1.78%
ROA(3y)11.41%
ROA(5y)12.2%
ROE(3y)40.58%
ROE(5y)38.06%
ROIC(3y)20.03%
ROIC(5y)20.57%
ROICexc(3y)43.96%
ROICexc(5y)44.35%
ROICexgc(3y)95.79%
ROICexgc(5y)98.86%
ROCE(3y)28.49%
ROCE(5y)29.26%
ROICexcg growth 3Y-16.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y-9.68%
ROICexc growth 5Y-2.6%
OM growth 3Y0.47%
OM growth 5Y5.87%
PM growth 3Y-4.31%
PM growth 5Y7.81%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.33
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF 12.7
Debt/EBITDA 1.34
Cap/Depr 245.84%
Cap/Sales 5.29%
Interest Coverage 9.15
Cash Conversion 41.97%
Profit Quality 21.29%
Current Ratio 1.75
Quick Ratio 1.75
Altman-Z 3.65
F-Score6
WACC7.85%
ROIC/WACC2.82
Cap/Depr(3y)181.12%
Cap/Depr(5y)138.87%
Cap/Sales(3y)3.56%
Cap/Sales(5y)2.84%
Profit Quality(3y)80.71%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4%
EPS 3Y21.98%
EPS 5Y26.76%
EPS Q2Q%-18.6%
EPS Next Y-8.8%
EPS Next 2Y2.91%
EPS Next 3Y4.74%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y12.78%
Revenue growth 5Y15.56%
Sales Q2Q%-4.06%
Revenue Next Year-3.03%
Revenue Next 2Y-0.05%
Revenue Next 3Y1.48%
Revenue Next 5YN/A
EBIT growth 1Y-0.65%
EBIT growth 3Y13.31%
EBIT growth 5Y22.35%
EBIT Next Year18.6%
EBIT Next 3Y12.79%
EBIT Next 5YN/A
FCF growth 1Y142.73%
FCF growth 3Y-46.37%
FCF growth 5Y-25.68%
OCF growth 1Y372.16%
OCF growth 3Y-12.08%
OCF growth 5Y0.21%